Randomized study of postoperative chemotherapy (CT) after preoperative chemoradiation (CTRT) in locally advanced rectal cancer (LARC). Preliminary results

@article{Cionini2001RandomizedSO,
  title={Randomized study of postoperative chemotherapy (CT) after preoperative chemoradiation (CTRT) in locally advanced rectal cancer (LARC). Preliminary results},
  author={L. Cionini and B. Manfredi and A. Sainato and M. Panichi and M. L. Friso and V. Valentini and M. Lupattelli and A. Paoli},
  journal={European Journal of Cancer},
  year={2001},
  volume={37}
}
Chemotherapy: Adjuvant and Neoadjuvant Approaches
TLDR
The current evidence for adjuvant chemotherapy and the potential role of the novel strategy of neoadjuvant chemotherapy in the treatment of rectal cancer are evaluated. Expand
Neoadjuvant Radiation and Combined Modality Therapy
The dramatic improvement in local control of rectal cancer observed during the last decades is to be attributed to attention to surgical technique and to the introduction of neoadjuvant therapyExpand
Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis.
  • P. Khrizman, J. Niland, +9 authors A. Benson
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2013
TLDR
Even at specialty cancer centers, a sizeable minority of patients with rectal cancer treated with curative-intent neoadjuvant chemoradiotherapy do not complete postoperative chemotherapy. Expand
Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation?
TLDR
NACT before CRT delivers does not compromise CRT but has not increased pCR rates, R0 resection rate, improved DFS or reduced metastases, and the utility of NACT alone could be explored compared with SCPRT or CRT in selected patients with rectal cancer where the impact of radiotherapy on DFS and OS is marginal. Expand
Progress in Rectal Cancer Treatment
The dramatic improvement in local control of rectal cancer observed during the last decades is to be attributed to attention to surgical technique and to the introduction of neoadjuvant therapyExpand
Will Adjuvant Chemotherapy Improve Outcome After Preoperative Chemoradiation
TLDR
There is a great need for well-designed trials to answer the fundamental question whether adjuvant chemotherapy in rectal cancer provides any benefit after preoperative chemoradiation. Expand
Point: short-course radiation therapy is preferable in the neoadjuvant treatment of rectal cancer.
TLDR
Short-course preoperative radiation with a long interval to surgery is a valuable option for patients unfit for chemotherapy, with unresectable cancer or with a small tumor that is amenable to local excision and indicates that short-course radiation is preferable to chemoradiation for resectable cancers. Expand
Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials.
TLDR
The body of evidence indicates that patients downstaged after radio(chemo)therapy to ypT0-2N0 disease are not candidates for testing adjuvant chemotherapy in future trials due to the considerable over-treatment anticipated by this manoeuvre. Expand
Multidisciplinary management in rectal cancer.
TLDR
Future studies will determine the optimal regimen for inducing complete responses in locally advanced disease and whether the intensification of local treatments could enable the use of more conservative treatments, as for other tumour locations. Expand
Optimal Adjuvant Therapy for Patients with Resected Rectal Cancers
Until fairly recently, patients with stage II and III rectal adenocarcinomas were routinely administered postoperative combined chemoradiotherapy, which was associated with a significant survivalExpand
...
1
2
3
...